Icynene is a Canadian company that produces open-cell foam insulation, a product widely used in residential and commercial buildings for energy efficiency.
The Moffitt v.
Also worth reading: What are the details of the Samsung class action lawsuit and how could it affect consumers? · What are the current Kansas medical malpractice damage cap limits and how do they affect lawsuit payouts in 2026? · Are lawsuit settlement checks taxable income in 2026 and how should I report them?
Icynene lawsuit, filed in 2006, highlighted the potential health risks associated with spray foam insulation, leading to significant scrutiny of Icynene's products.
The lawsuit was settled out of court just a week before it was scheduled for jury trial, indicating the company's desire to avoid a public trial and potential reputational damage.
Spray foam insulation contains chemicals that can emit volatile organic compounds (VOCs) during and after installation, raising concerns about indoor air quality.
Health risks associated with spray foam insulation include respiratory issues, skin irritation, and potential long-term exposure effects, which have been at the center of various lawsuits against multiple manufacturers.
Icynene insulation is often confused with other spray foam products, which can lead to misconceptions about performance and safety, as many consumers use the brand name generically.
The lawsuits against Icynene and other spray foam manufacturers claim that these products can cause serious health problems for those living in homes where the insulation has been installed.
Legal actions against Icynene are part of a broader trend, with numerous manufacturers facing similar lawsuits, creating an "avalanche" of complaints in states across the US
Scientific studies have shown that certain chemicals used in spray foam insulation can remain in the environment and potentially affect human health long after installation.
Icynene's insulation is marketed for its energy efficiency and soundproofing properties, but the potential health risks have raised questions about its overall safety.
The case law surrounding Icynene indicates a growing awareness and concern among consumers regarding the long-term effects of chemical exposure from building materials.
Multi-District Litigation (MDL) is likely to consolidate many of the lawsuits against spray foam manufacturers, streamlining the legal process and potentially leading to more significant settlements or changes in industry practices.
The insulation's open-cell structure allows for moisture absorption, which can lead to mold growth if not installed correctly, further complicating health and safety concerns.
Some independent dealers trained by Icynene have been implicated in lawsuits due to improper installation practices, highlighting the importance of qualified professionals in handling spray foam products.
The chemical components used in Icynene spray foam insulation include isocyanates, which are known to be irritants and potentially hazardous in high concentrations.
Regulatory agencies, such as the Environmental Protection Agency (EPA), have issued guidelines for the safe use of spray foam insulation, emphasizing the need for proper ventilation during installation.
The settlement of the Moffitt case and similar lawsuits has prompted Icynene and other manufacturers to reevaluate their safety protocols and the transparency of their product ingredients.
Consumer awareness regarding the potential risks associated with spray foam insulation has grown, leading some homeowners to seek alternative insulation options that are perceived as safer.
The outcome of ongoing litigation against Icynene and its competitors may influence future regulations regarding the use of chemical substances in building materials.
Understanding the complexities of the issues surrounding spray foam insulation, including its benefits and risks, is crucial for homeowners considering its installation in their properties.